Journal of Biopharmaceutical Statistics · 1998 · 113 citations · 15 references
MedicineBiostatisticsPharmacologyBayesian BiostatisticsBayesian Data AnalysisDose-response ModelingAdverse Drug Reaction PredictionBayesian Clinical TrialsBayesian InferenceDose CalculationDose OptimizationDose SelectionBayesian Dose EscalationBayesian Dose OptimizationBayesian Dose-findingClinical Trial Design Under Bayesian FrameworkDecision ProceduresDose-finding Trial DesignLogistic RegressionModel-based Dose Optimization
Early-phase clinical trials, conducted to determine the appropriate dose of an experimental drug to take forward to later trials, are considered. The objective is to find the dose associated with some low probability of an adverse event. A Bayesian model is presented, and a decision-theoretic procedure for finding the optimal doses for each of a series of cohorts of subjects is derived. The procedure is flexible and can easily be conducted using standard statistical software. The results of simulations investigating the properties of the procedure are presented.
15
Design and Analysis of Phase I Clinical Trials
Barry E. Storer · Biometrics · 1989 · 932 citations
Continual Reassessment Method: A Likelihood Approach
John O’Quigley, Larry Z. Shen · Biometrics · 1996 · 376 citations